Actor Zeppo Marx patented a "Cardiac Pulse Rate Monitor" in 1969.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8173795 | Methods and compositions for identifying and characterizing hepatitis C The invention provides novel methods and compositions for amplifying portions of the HCV genome. The nucleic acid sequences set forth as SEQ ID NOS:1-64 derived from HCV cDNA and functional equivalents thereof, kits containing same, and methods employing same, are u... | 05/08/2012 |
| 8148350 | Carbohydrate composition for flat glucose response A low-glycemic available carbohydrate composition of the invention contains the following components: (i) 5-60 wt. % of one or more monosaccharides selected from monosaccharides other than glucose and fructose, in particular galactose, ribose and mannos... | 04/03/2012 |
| 8147875 | Dermatologic use of milk proteins The invention provides a method for the treatment of acne comprising orally administering to a person suffering from acne an effective amount of a whey protein fraction containing lactoferrin, and preferably containing further specific whey proteins. The lactoferrin... | 04/03/2012 |
| 8143235 | Use of dietary fibres against muscle wasting A composition nutritional containing dietary fibres is useful for the treatment of muscle wasting, if the dietary fibre comprise at least 30 wt. % of galacto-oligosaccharides or other oligosaccharides having mainly anhydropyranose units, and having a chain length of... | 03/27/2012 |
| 8137914 | Variants of alpha-fetoprotein coding and expression sequences The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemo... | 03/20/2012 |
| 8133558 | Polylactic acid blown film and method of manufacturing same The invention provides polylactic acid (PLA) films substantially free of plasticizers and methods of manufacturing same by blown film process are provided. PLA films are environmentally degradable and have applications in, at least, packaging and labeling. ... | 03/13/2012 |
| 8124585 | Composition for relieving discomfort The invention relates to a method of controlling feelings of pain in infants or diseased or elderly persons using a complete nutrition or a nutritional supplement. The method comprises administering increased levels of folic acid, vitamin B6 and vitamin B12 or their... | 02/28/2012 |
| 8119657 | Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methods Enantiomerically pure (S)-2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one, (S)-AV1013, is a candidate therapeutic for treating neuropathic pain, addiction behavior and drug withdrawal symptoms. Also described are methods for preparing and using (S)-AV... | 02/21/2012 |
| 8119155 | Nutrition with lipids and non-digestible saccharides The invention relates to a liquid nutrition comprising short chain fatty acyl chains, polyunsaturated fatty acyl chains, vegetable oil and a non-digestible, fermentable saccharide. The composition is particular suitable for use as an infant nutrition. The compositio... | 02/21/2012 |
| 8114441 | Immune stimulatory infant nutrition A nutritional or pharmaceutical composition containing a fat component, a protein component and a carbohydrate component and comprising whey and casein. The composition has a weight ratio of casein to whey is 1:1 to 1:2.4 and that the composition contains: a) at lea... | 02/14/2012 |
| 8105963 | Composition for the protection of a shaped article against corrosion The invention relates to a composition for the protection of a shaped article against corrosion, said composition comprising (a) a polyisobutene having a glass transition temperature of less than −20° C. and surface tension of less than 40 mM/m at a temperature a... | 01/31/2012 |
| 8076313 | Composition containing fermentable polysaccharides The present invention relates to a composition to a nutritional composition comprising 0.1 to 15 gram fermentable e partially hydrolysed gum having a degree of polymerization between 10 and 300 per 100 gram dry weight of the composition and 0.1 to 15 gram fermentabl... | 12/13/2011 |
| 8067357 | Annexin derivatives suitable for pretargeting in therapy and diagnosis The present invention provides methods and compositions for the treatment and diagnosis of diseases such as neoplastic diseases, neurodegenerative diseases, cardiovascular diseases, autoimmune diseases, and inflammatory diseases. The methods are based on the concept... | 11/29/2011 |
| 8048997 | Process for drying uronic acid oligosaccharides The present invention relates to a process for spray drying uronic acid oligosaccharides and to a powder compositions thus obtained. Typically the powder composition comprises between 25 and 100 wt.% uronic acid oligosaccharide with a DP between 2 and 50 based on to... | 11/01/2011 |
| 8017149 | Modified release preparations containing oxcarbazepine and derivatives thereof Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal rele... | 09/13/2011 |
| 8003600 | Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies It has been found that high amounts of aspartate equivalents in combination with vitamin B12 and/or biotin, especially in relative absence of glutamate equivalents, improve the metabolism of ketobodies and/or lactate in a mammal's body, especially in diseased or tra... | 08/23/2011 |
| 7999007 | Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reduc... | 08/16/2011 |
| 7998545 | Polylactic acid shrink films and methods of casting same A heat-shrinkable polylactic acid (PLA) film and a method of its manufacture are provided. In an exemplary embodiment, the PLA films exhibit heat-induced shrinkage in the transverse direction with little to no concomitant shrinkage in the machine direction. The film... | 08/16/2011 |
| 7981684 | Methods and biomarkers for diagnosing and monitoring psychotic disorders A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the level of a biomarker selected from clusterin precursor, inter α-trypsin inhibitor, IgM, apolipoprotein A2 and α2 H5 gly... | 07/19/2011 |
| 7977066 | Method for preparing tryptophan rich peptides Described is a method for selectively isolating tryptophan containing peptides from an aqueous peptide mixture, including the steps of controlling the pH of the aqueous peptide mixture to 4.0-6.0, forming a precipitate of tryptophan containing peptides, and isolatin... | 07/12/2011 |
| 7977063 | Method for determining an allergic response The present invention concerns a method for determining an allergic response by determining the extent of degranulation of human IgE sensitized cells upon activation by allergens in food products. ... | 07/12/2011 |
| 7968088 | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient Intravenous administration of bone marrow cells collected from rat bone marrow or peripheral blood to a rat cerebral infarction model was found to be effective in treating cerebral infarction. Human and murine bone marrow stem cells showed similar effects. Mesenchym... | 06/28/2011 |
| 7938865 | Method of dyeing a substrate with a reactive dyestuff in supercritical or near supercritical carbon dioxide The present invention relates to a method of dyeing a substrate with a reactive dyestuff in supercritical or near supercritical carbon dioxide, said substrate being selected from the group consisting of cellulose fibers, modified cellulose fibers, protein fibers and... | 05/10/2011 |
| 7932353 | Non-glycosylated recombinant collagen-like polypeptides The invention relates to recombinant collagen like polypeptides that are not glycosylated thereby reducing the immunogenicity of recombinant collagen-like polypeptides while at the same time preventing or reducing phosphorylation of these polypeptides. Such non-glyc... | 04/26/2011 |
| 7923520 | High refractive index monomers and (co)polymers prepared therefrom The present invention relates to high refractive index monomers according to formula (I) and (co)polymers comprising such high refractive index monomers. The 5 (co)polymers are highly suitable for the manufacture of optical articles, in particular flexible optical a... | 04/12/2011 |
| 7910131 | Method of treating seizures using modified release formulations of oxcarbazepine Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal rele... | 03/22/2011 |
| 7910128 | Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics Disclosed are pharmaceutical compositions, particularly oral dosage forms, which comprise two or more enteric coating materials, either as a coating or as part of a matrix dosage form, and methods of making and using the same. The compositions are characterized by h... | 03/22/2011 |
| 7893070 | Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion The present invention relates to a method of facilitating the birth process of placental mammals, especially to a method of reducing delays in the birth process and, thereby, complications resulting there from that may negatively affect the health and wellbeing of t... | 02/22/2011 |
| 7887925 | Composition for the protection of a shaped article against corrosion The invention relates to a composition for the protection of a shaped article against corrosion, said composition comprising (a) a polyisobutene having a glass transition temperature of less than −20° C. and surface tension of less than 40 mM/m at a temperature a... | 02/15/2011 |
| 7846517 | Polylactic acid shrink films and methods of manufacturing same A heat-shrinkable polylactic acid (PLA) film and a method of its manufacture are provided. In an exemplary embodiment, the PLA films exhibit heat-induced growth in the cross direction with concomitant shrinkage in the machine direction. The films may comprise any gr... | 12/07/2010 |
| 7879197 | Purification of aqueous solutions of organic acids The invention relates to a method and a device for the purification of an aqueous solution of an organic acid having a boiling point at atmospheric pressure of less than 450° C., which further has approximately 275 g carboxylate ions/l or less, preferably 250 g car... | 02/01/2011 |
| 7875153 | Purification of aqueous solutions of organic acids The invention relates to a method and a device for the purification of an aqueous solution of an organic acid having a boiling point at atmospheric pressure of less than 450° C., which-further has approximately 275 g carboxylate ions/1 or less, preferably 250 g car... | 01/25/2011 |
| 7838621 | Preparation of supramolecular polymer containing quadruple hydrogen bonding units in the polymer backbone The present invention relates to a supramolecular polymer comprising quadruple hydrogen bonding units within the polymer backbone, wherein at least a monomer comprising a 4H-unit is incorporated in the polymer backbone via at least two reactive groups up to four rea... | 11/23/2010 |
| 7824911 | Hepatic stellate cell progenitors and methods of isolating same The present invention relates to precursor cells to hepatic stellate cells, compositions comprising same and methods of isolating same. The surface antigenic profile of the precursors is MHC class Ia negative, ICAM-1+, VCAM-1+, β3-integrin | 11/02/2010 |
| 7803771 | Recombinant gelatin particles for cell adhesion The present invention relates to cell carrier particles prepared from recombinantly produced gelatins comprising at least two outer lysine residues which are separated by at least 25 percent of the total number of amino acids in the recombinant gelatin polypeptide. ... | 09/28/2010 |
| 7786326 | Polyacylurethanes based on diisocyanates and polyesterpolyols The present invention relates to a polyacylurethane having the following general formula (I) and a process for the preparation of such polyacylurethane. Preferred embodiments of the polyacylurethanes according to the invention have elastomeric properties. The polyac... | 08/31/2010 |
| 7785782 | Device and method for in-line blood testing using biochips A device for in-line blood screening and testing using biochips is disclosed. The screening methods include nucleic acid amplification techniques and antibody/antigen assays to detect target molecules and agents indicative of infectious diseases or metabolic disease... | 08/31/2010 |
| 7772217 | Preparation for the prevention and/or treatment of vascular disorders The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; | 08/10/2010 |
| 7766980 | Method for the preparation of precipitates The present invention concerns a method for the controlled precipitation of organic molecules which comprises the use of apparatus that is normally used in the field of photography. ... | 08/03/2010 |
| 7759118 | Proliferation of hepatocyte precursors A composition which comprises an animal cell population which contains immature animal cells. The immature animal cells are characterized by expression of alpha-fetoprotein or lack of essential expression of alpha-fetoprotein and albumin, and at least a portion of s... | 07/20/2010 |